Article Information
History
- May 2, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Gavin C. Sampey1,
- David M. Irlbeck1,2,
- Edward P. Browne1,
- Matthew Kanke3,
- Alecia B. McAllister1,
- Robert G. Ferris1,2,
- Jessica H. Brehm1,2,
- David Favre1,2,
- Jean-Pierre Routy4,
- Corbin D. Jones3,
- Nancie M. Archin1,
- David M. Margolis1 and
- Richard M. Dunham1,2,*
- 1UNC HIV Cure Center, University of North Carolina at Chapel Hill and Qura Therapeutics, Chapel Hill, NC, USA
- 2HIV Discovery Performance Unit, GlaxoSmithKline Research and Development, Research Triangle Park, NC, USA
- 3University of North Carolina, Department of Biology and Department of Genetics, Chapel Hill, NC, USA
- 4McGill University Health Centre, Chronic Viral Infection Service and Division of Hematology. Montreal, QC, Canada
- ↵*Corresponding author; Genetic Medicine Bldg., CB 7042, 120 Mason Farm Rd, Rm 2096, Chapel Hill, NC 27599-7042, +19194450379 richard.m.dunham{at}gsk.com